Shorting the losers and backing the winners: Plato’s all-weather investment strategy

Home  >  videos  >  shares  >  shorting the losers and backing the winners platos all weather investment strategy

AW
Angelina Wu00:05 Play

Our first speaker from the global perspective is Mr. Dave Allen, PLATO Investment Management's Head of Longshore Strategies and Portfolio Manager of the PLATO Global Alpha Fund.

AW
Angelina Wu00:17 Play

The PLATO Global Alpha Fund is a longshore global equities fund dedicated to proving investors of weather investment solutions that can generate alpha throughout the cycle.

AW
Angelina Wu00:31 Play

the team isn't mandated to stick to a particular style like value, growth, or quality.

AW
Angelina Wu00:37 Play

Instead, the fund is focused on generating consistent features so those in the accumulation phase can grow their assets over time.

AW
Angelina Wu00:47 Play

The fund aims to outperform the MSCI world net returns on the hedge index by 4% per annum after fees over the median long term prior to Plato

AW
Angelina Wu00:59 Play

Dave worked for J.P. Morgan Asset Management in London for 15 years, where he designed and launched the J.P. Morgan Euro Equity Plus Active Extension Fund, which grew to €6 billion.

AW
Angelina Wu01:15 Play

Dave's presentation topic is shorting the losers and backing the winners.

AW
Angelina Wu01:21 Play

Plato's all-weather investment strategy.

AW
Angelina Wu01:25 Play

Welcome, Dave.

DD
Dr Dave Allen01:26 Play

Thank you so much for having me on.

DD
Dr Dave Allen01:29 Play

I really appreciate it.

DD
Dr Dave Allen01:31 Play

So the fund that I'll talk about today is the PLATO Global Alpha Fund.

DD
Dr Dave Allen01:37 Play

So this strategy has MSEO world benchmark and is suitable as a core allocation for your equity exposure or a satellite allocation.

DD
Dr Dave Allen01:49 Play

What's really distinctive about this strategy is it's 150% long and 50% short.

DD
Dr Dave Allen01:55 Play

What does that mean?

DD
Dr Dave Allen01:56 Play

Well, it means we've got 50% more firepower for our best ideas, but we're also got 50% short.

DD
Dr Dave Allen02:03 Play

That gives us the ability to make money through the companies that are going to underperform and in this environment where rates are going through the roof, companies that have been limping along and never making a profit are really being found out.

DD
Dr Dave Allen02:18 Play

The performance to data have been very strong in last year's value-dominated market and then this year's growth-dominated market.

DD
Dr Dave Allen02:26 Play

We're actually outperforming the MSUI world by almost 9% per annum since the strategy was launched.

DD
Dr Dave Allen02:36 Play

If we look at the performance, as we alluded to, of strategies that I've run in the past, we have the active extension strategy here on the left hand side from my time with JP Morgan, where over a decade long period, we outperformed by about 4% per annum relative to the MSCI benchmark.

DD
Dr Dave Allen02:56 Play

On the right hand side, this is a long shorter, actually a market usual hedge fund strategy where we generated an annualized alpha of around 10%.

DD
Dr Dave Allen03:05 Play

per year.

DD
Dr Dave Allen03:08 Play

So we have a fantastic, you know we've got 10-11 billion of assets under management and we're sort of known and loved for the Australian income strategy.

DD
Dr Dave Allen03:19 Play

But what many of you may not be aware of is we've got a tremendous depth of talent in global longshore.

DD
Dr Dave Allen03:28 Play

George Platt, of course, was the head of the Macquarie hedge fund group for many years.

DD
Dr Dave Allen03:33 Play

Charles was largely his right hand man.

DD
Dr Dave Allen03:36 Play

And we have Don

DD
Dr Dave Allen03:39 Play

The Dr Don of course launched Australia's first ever 130-30 strategy when he was back at State Street well over a decade ago and Chanel as well with extensive long short experience.

DD
Dr Dave Allen03:53 Play

And they're the faces that are really driving the performance that we've delivered so far.

DD
Dr Dave Allen04:03 Play

The key investment philosophy behind everything we do is a company for us to invest, it has to be a high quality business.

DD
Dr Dave Allen04:10 Play

But high quality businesses, the market's quite efficient, and they'll tend to trade at a premium to the market.

DD
Dr Dave Allen04:16 Play

So we're looking for those high quality businesses that for some reason the market isn't

DD
Dr Dave Allen04:22 Play

isn't it really accounting for that value correctly.

DD
Dr Dave Allen04:27 Play

Of course, cheap names can remain cheap for 5, 10 years, good being right if you write 5, 10 years too early.

DD
Dr Dave Allen04:33 Play

So we'll always wait for those cheap high quality names to have that profit potential to be unlocked with some sort of a catalyst or a change in sentiment.

DD
Dr Dave Allen04:44 Play

The final hurdle that a company must

DD
Dr Dave Allen04:46 Play

overcome for it to make it into our portfolio is a system of over 100 red flags that we've developed for almost a decade.

DD
Dr Dave Allen04:56 Play

The red flags is one of the most distinctive parts of the PLATO investment process.

DD
Dr Dave Allen05:02 Play

Really, the red flags are about avoiding landmines and also identifying great short opportunities.

DD
Dr Dave Allen05:11 Play

So if we see a cluster of red flags where a company has

DD
Dr Dave Allen05:15 Play

weak governance, signs of financial distress, really aggressive accounting.

DD
Dr Dave Allen05:20 Play

then those companies we really try and steer clear of.

DD
Dr Dave Allen05:24 Play

If a company has eight or more red flags, then that company on average will underperform the benchmark by about 20% over the next 12 months.

DD
Dr Dave Allen05:34 Play

It's a pretty substantial number.

DD
Dr Dave Allen05:35 Play

If you can just avoid those blow ups in your portfolio, you're halfway there.

DD
Dr Dave Allen05:40 Play

But if you can go one step further and short those names, then you can generate some fantastic alpha.

DD
Dr Dave Allen05:46 Play

And indeed,

DD
Dr Dave Allen05:47 Play

90 to 95 percent of the alpha that we've generated on the strategy to date has actually been on that short side.

DD
Dr Dave Allen05:56 Play

There's some really interesting names globally and in Australia at the moment that have a very large number of red flags.

DD
Dr Dave Allen06:04 Play

So Brainchip, this is a company

DD
Dr Dave Allen06:06 Play

that has 22 red flags.

DD
Dr Dave Allen06:09 Play

And that out of the 10,000 companies we look at globally, they're actually, it's the second largest number of red flags.

DD
Dr Dave Allen06:16 Play

And it's a company that had a valuation around $3 billion around the start of the year.

DD
Dr Dave Allen06:21 Play

And this is a company that's got less revenue than some cafes.

DD
Dr Dave Allen06:26 Play

So there are a wealth of opportunities out here.

DD
Dr Dave Allen06:29 Play

I think it's almost a once in a lifetime opportunity for shorting strategies to make money on these sorts of names.

DD
Dr Dave Allen06:37 Play

On the long side, though, there's some names we really like.

DD
Dr Dave Allen06:41 Play

BMW is a great value company.

DD
Dr Dave Allen06:44 Play

You know, it's incredible to me.

DD
Dr Dave Allen06:45 Play

Such a storied name can trade at six and a half times earnings.

DD
Dr Dave Allen06:51 Play

And they've got a huge amount of growth even in their EV space growing.

DD
Dr Dave Allen06:55 Play

35% per year, which is the same as Tesla.

DD
Dr Dave Allen06:59 Play

We look to drive really consistent returns by having the very best value names, the best growth names and the best quality names in the portfolio.

DD
Dr Dave Allen07:06 Play

So not tied to any one thematic or one style.

DD
Dr Dave Allen07:11 Play

A great growth name that we like in the portfolio is Novo Nordisk.

DD
Dr Dave Allen07:14 Play

Of course, they're

DD
Dr Dave Allen07:16 Play

They're at the forefront of the anti-obesity drugs, 80-90% market share in that.

DD
Dr Dave Allen07:23 Play

ASML, they're at the very apex of the semiconductor supply chain to actually make the machines that make the chips.

DD
Dr Dave Allen07:32 Play

that are behind all of the most advanced AI.

DD
Dr Dave Allen07:35 Play

So whoever wins that AI race, ASML will win irrespective of that.

DD
Dr Dave Allen07:40 Play

And by having those exposures to some of these great companies that I've personally been invested in for well over a decade, we can drive consistent returns and not just feast and famine returns that you've seen from some highly concentrated managers.

DD
Dr Dave Allen07:56 Play

And that's exactly what we're seeing here.

DD
Dr Dave Allen07:58 Play

The outperformance of the strategy since launch is almost 9% after fees.

DD
Dr Dave Allen08:05 Play

But I think equally gratifying, if you look on the right hand side, the upside and downside capture of the strategy.

DD
Dr Dave Allen08:11 Play

So the upside capture is about 1.25.

DD
Dr Dave Allen08:14 Play

So that means when the market's going up, we're going up more than the market.

DD
Dr Dave Allen08:18 Play

The downside captures about 0.8.

DD
Dr Dave Allen08:21 Play

So when the market's going down, we're preserving capital better than the market.

DD
Dr Dave Allen08:25 Play

So that provides those nice characteristics we like to see as investors.

DD
Dr Dave Allen08:30 Play

That's translated to very consistent returns over time.

DD
Dr Dave Allen08:33 Play

This shows the performance of the strategy compared to the 40 largest competitor funds.

DD
Dr Dave Allen08:41 Play

And you can see that we've added alpha consistently in a pretty difficult period for investors with lots of different themes.

DD
Dr Dave Allen08:49 Play

So what are the key takeaways that we can deliver that high alpha as we've done here and in past lives, but without that high concentration and those severe drawdowns, the focus really on that all weather performance, whether it's a recession or whether it's a growth market where we're not looking to make excuses, we're looking to make returns irrespective.

DD
Dr Dave Allen09:12 Play

The red flags are absolutely critical within that to A,

DD
Dr Dave Allen09:17 Play

avoid landmines on the long side, but they really drive out from the short side.

DD
Dr Dave Allen09:21 Play

And ultimately, that's all contributed to some very strong performance in quite a challenging period for markets.

DD
Dr Dave Allen09:28 Play

Are there any questions that you'd like to go through?

AW
Angelina Wu09:33 Play

Yeah, thanks, Dave.

AW
Angelina Wu09:34 Play

Absolutely.

AW
Angelina Wu09:35 Play

There are a few questions here.

AW
Angelina Wu09:36 Play

The first question we have is around AI.

AW
Angelina Wu09:40 Play

So we know that there is a lot of hype surrounding AI at the moment.

AW
Angelina Wu09:44 Play

So how are you looking at AI?

AW
Angelina Wu09:47 Play

The second part of the question is, any more broadly, how do you play these thematic steps emerge from time to time with so much hype?

DD
Dr Dave Allen09:58 Play

Yeah, I think it's an excellent question.

DD
Dr Dave Allen10:01 Play

And many people hadn't even heard of CHAP GPT until last November.

DD
Dr Dave Allen10:08 Play

And now it's upending almost every industry you can think of.

DD
Dr Dave Allen10:14 Play

In such a rapidly changing space, I think it is difficult though to pick the eventual winners downstream.

DD
Dr Dave Allen10:23 Play

So it's very much our philosophy that you want to have more of a picks and shovels approach where you're investing right at the apex of the supply chain.

DD
Dr Dave Allen10:33 Play

So ASML is a name I mentioned just earlier.

DD
Dr Dave Allen10:37 Play

They make the deep ultraviolet lithography machines that are critical to every single AI process in the world.

DD
Dr Dave Allen10:45 Play

And that's a way that you can get access to the thematic, but without taking on too much idiosyncratic risk as the landscape changes from week to week and month to month.

AW
Angelina Wu10:57 Play

That makes sense.

AW
Angelina Wu10:59 Play

And can you touch on why you do think investors should consider allocating to a long, short strategy as opposed to just all alone only?

DD
Dr Dave Allen11:09 Play

Yeah, another good question, I think.

DD
Dr Dave Allen11:15 Play

Outperforming consistently with a purely long-only strategy is difficult.

DD
Dr Dave Allen11:20 Play

If you want to generate income, long-only is perfect.

DD
Dr Dave Allen11:24 Play

It's the perfect vehicle for that.

DD
Dr Dave Allen11:25 Play

But if you want to generate alpha, long-only is almost like going to war with a water pistol.

DD
Dr Dave Allen11:31 Play

It's hard yakka.

DD
Dr Dave Allen11:33 Play

Say that you identify that a company's fraud,

DD
Dr Dave Allen11:35 Play

All you can do is not hold it.

DD
Dr Dave Allen11:37 Play

But the second you can be long short, you've taken off the handcuffs and you can generate a huge amount of alpha on the short side.

DD
Dr Dave Allen11:44 Play

And this environment where there's a lot of dispersion between your winners and your losers, companies are being found out that had lofty valuations that are being torched by rapidly rising rates.

DD
Dr Dave Allen11:57 Play

Yeah, it's a great environment for longshore without a doubt.

DD
Dr Dave Allen12:00 Play

And we've definitely had that tailwind behind us in generating the strong performance that we have.

AW
Angelina Wu12:07 Play

Well, thank you, Dave.

AW
Angelina Wu12:09 Play

Great to see you.

AW
Angelina Wu12:10 Play

Take care.

DD
Dr Dave Allen12:12 Play

Thank you so much.

Shorting the losers and backing the winners: Plato’s all-weather investment strategy

3 years ago

Dr David Allen will discuss why investors should have exposure to a global equities strategy that can generate alpha from not only companies on the rise, but also companies with falling share prices. Find out how Plato’s unique 100+ red flags model identifies investment opportunities and some of stocks currently in the sights of the Plato team. The Plato Global Alpha Fund is a long/short global equities fund dedicated to proving investors all-weather investment solutions that can generate alpha throughout the cycle. Prior to Plato, David Allen worked for JP Morgan Asset Management in London for 15 years, where he designed and launched the JP Morgan Europe Equity Plus active-extension fund which grew to €6 billion.

Disclaimer

  • • The presentations made during this seminar are for informational and promotional purposes only.

  • • Any comments made or information provided does not consider the appropriateness for you having regard to your particular objectives, personal/financial situation and needs. Before investing you should consider independent professional financial advice.

  • • No comments made or information provided constitutes advice, an invitation, or an offer to buy any security or other financial product or engage in any investment activity.

  • • All securities and financial products involve risks.

  • • Past performance of any product is not a reliable indication of future performance.

  • • Read carefully the governing documents of a product’s offering such as its PDS or information memorandum.

  • • InvestmentMarkets does not vet, endorse or recommend any product the subject of the presentations and is only facilitating the exposure of the product.

  • • These presentations were made as at 25-27 July, 2023 and therefore relevant facts, the economic environment, governing documentation and the law upon which they were based may change after that date such that the accuracy and reliability of their content may be affected.

More Videos

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌